Apple with a genius plan, coming with something new for iPhone users.

The initiative includes a partnership with Synchron, a start in neurotechnology that produces brain-computer interface implants (BCI) called Stentrode, broadcast Telegrafi.

Steroids allow users with severe motor damage, such as those caused by amyotrophic lateral sclerosis (ALS), to control Apple devices using nerve signals discovered by blood vessels placed on the motor cortex of the brain.

Synchron has been implanting Stantrode into ten patients since 2019. A testist from Pennsylvania with ALS, which cannot use arms or hands, can use Apple Vision Pro and other Apple devices just by thinking, though it functions slower than conventional data mechanisms.

Apple seems to be planning to increase BCI support under its existing access to Sitch Control, which allows data from non-standard devices such as arid and adaptive devices. The company reportedly intends to publish this new standard later in 2025.

Synchron's approach differs significantly from that of other companies like Neuralink, which is developing a more invasive implant called N1.

The Neuralink device contains more than 1,000 electrodes implanted directly into brain tissue, providing a nerve data flow with higher resolution.

This allows more complex control, including the movement of the cursor on screen and writing using your brain's power. /Periscope/